64 related articles for article (PubMed ID: 21459582)
1. Fluorescent phosphoinositide 3-kinase inhibitors suitable for monitoring of intracellular distribution.
Kim D; Lee H; Jun H; Hong SS; Hong S
Bioorg Med Chem; 2011 Apr; 19(8):2508-16. PubMed ID: 21459582
[TBL] [Abstract][Full Text] [Related]
2. Fluorescent cyclin-dependent kinase inhibitors block the proliferation of human breast cancer cells.
Yenugonda VM; Deb TB; Grindrod SC; Dakshanamurthy S; Yang Y; Paige M; Brown ML
Bioorg Med Chem; 2011 Apr; 19(8):2714-25. PubMed ID: 21440449
[TBL] [Abstract][Full Text] [Related]
3. Development of new fluorescent xanthines as kinase inhibitors.
Kim D; Jun H; Lee H; Hong SS; Hong S
Org Lett; 2010 Mar; 12(6):1212-5. PubMed ID: 20184370
[TBL] [Abstract][Full Text] [Related]
4. Discovery of new aminopyrimidine-based phosphoinositide 3-kinase beta (PI3Kβ) inhibitors with selectivity over PI3Kα.
Kim J; Hong S; Hong S
Bioorg Med Chem Lett; 2011 Dec; 21(23):6977-81. PubMed ID: 22030027
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of imidazopyridine analogues as inhibitors of phosphoinositide 3-kinase signaling and angiogenesis.
Kim O; Jeong Y; Lee H; Hong SS; Hong S
J Med Chem; 2011 Apr; 54(7):2455-66. PubMed ID: 21388141
[TBL] [Abstract][Full Text] [Related]
6. Structure-based virtual screening approach to the discovery of phosphoinositide 3-kinase alpha inhibitors.
Park H; Choi H; Hong S; Kim D; Oh DS; Hong S
Bioorg Med Chem Lett; 2011 Apr; 21(7):2021-4. PubMed ID: 21354792
[TBL] [Abstract][Full Text] [Related]
7. Potent, selective small molecule inhibitors of type III phosphatidylinositol-4-kinase α- but not β-inhibit the phosphatidylinositol signaling cascade and cancer cell proliferation.
Waring MJ; Andrews DM; Faulder PF; Flemington V; McKelvie JC; Maman S; Preston M; Raubo P; Robb GR; Roberts K; Rowlinson R; Smith JM; Swarbrick ME; Treinies I; Winter JJ; Wood RJ
Chem Commun (Camb); 2014 May; 50(40):5388-90. PubMed ID: 24366037
[TBL] [Abstract][Full Text] [Related]
8. WJD008, a dual phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin inhibitor, prevents PI3K signaling and inhibits the proliferation of transformed cells with oncogenic PI3K mutant.
Li T; Wang J; Wang X; Yang N; Chen SM; Tong LJ; Yang CH; Meng LH; Ding J
J Pharmacol Exp Ther; 2010 Sep; 334(3):830-8. PubMed ID: 20522531
[TBL] [Abstract][Full Text] [Related]
9. Block modification of rod-shaped pi conjugated carbon frameworks with donor and acceptor groups toward highly fluorescent molecules: synthesis and emission characteristics.
Ochi T; Yamaguchi Y; Wakamiya T; Matsubara Y; Yoshida Z
Org Biomol Chem; 2008 Apr; 6(7):1222-31. PubMed ID: 18362962
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of phosphoinositide-3-kinase: a structure-based approach to understanding potency and selectivity.
Sundstrom TJ; Anderson AC; Wright DL
Org Biomol Chem; 2009 Mar; 7(5):840-50. PubMed ID: 19225663
[TBL] [Abstract][Full Text] [Related]
11. 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5'-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
Li CM; Narayanan R; Lu Y; Hurh E; Coss CC; Barrett CM; Miller DD; Dalton JT
Int J Oncol; 2010 Oct; 37(4):1023-30. PubMed ID: 20811725
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of novel 4-morpholinopyrrolopyrimidine derivatives as potent phosphatidylinositol 3-kinase inhibitors.
Chen Z; Venkatesan AM; Dehnhardt CM; Ayral-Kaloustian S; Brooijmans N; Mallon R; Feldberg L; Hollander I; Lucas J; Yu K; Kong F; Mansour TS
J Med Chem; 2010 Apr; 53(8):3169-82. PubMed ID: 20334367
[TBL] [Abstract][Full Text] [Related]
13. Pyrazolobenzodiazepines: part I. Synthesis and SAR of a potent class of kinase inhibitors.
Liu JJ; Daniewski I; Ding Q; Higgins B; Ju G; Kolinsky K; Konzelmann F; Lukacs C; Pizzolato G; Rossman P; Swain A; Thakkar K; Wei CC; Miklowski D; Yang H; Yin X; Wovkulich PM
Bioorg Med Chem Lett; 2010 Oct; 20(20):5984-7. PubMed ID: 20832307
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of thiazolidinone derivatives as potential EGFR and HER-2 kinase inhibitors.
Lv PC; Zhou CF; Chen J; Liu PG; Wang KR; Mao WJ; Li HQ; Yang Y; Xiong J; Zhu HL
Bioorg Med Chem; 2010 Jan; 18(1):314-9. PubMed ID: 19914835
[TBL] [Abstract][Full Text] [Related]
15. Photophysical properties of oligophenylene ethynylenes modified by donor and/or acceptor groups.
Yamaguchi Y; Shimoi Y; Ochi T; Wakamiya T; Matsubara Y; Yoshida Z
J Phys Chem A; 2008 Jun; 112(23):5074-84. PubMed ID: 18491882
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of phosphatidylinositol 3-kinase (PI3K) inhibitory analogues of the sponge meroterpenoid liphagal.
Pereira AR; Strangman WK; Marion F; Feldberg L; Roll D; Mallon R; Hollander I; Andersen RJ
J Med Chem; 2010 Dec; 53(24):8523-33. PubMed ID: 21121631
[TBL] [Abstract][Full Text] [Related]
17. 4-(1,3-Thiazol-2-yl)morpholine derivatives as inhibitors of phosphoinositide 3-kinase.
Alexander R; Balasundaram A; Batchelor M; Brookings D; Crépy K; Crabbe T; Deltent MF; Driessens F; Gill A; Harris S; Hutchinson G; Kulisa C; Merriman M; Mistry P; Parton T; Turner J; Whitcombe I; Wright S
Bioorg Med Chem Lett; 2008 Aug; 18(15):4316-20. PubMed ID: 18625552
[TBL] [Abstract][Full Text] [Related]
18. Discovery of new azaindole-based PI3Kα inhibitors: apoptotic and antiangiogenic effect on cancer cells.
Hong S; Lee S; Kim B; Lee H; Hong SS; Hong S
Bioorg Med Chem Lett; 2010 Dec; 20(24):7212-5. PubMed ID: 21067921
[TBL] [Abstract][Full Text] [Related]
19. Development of a novel fluorescent probe for fluorescence correlation spectroscopic detection of kinase inhibitors.
Kawaguchi M; Terai T; Utata R; Kato M; Tsuganezawa K; Tanaka A; Kojima H; Okabe T; Nagano T
Bioorg Med Chem Lett; 2008 Jul; 18(13):3752-5. PubMed ID: 18524589
[TBL] [Abstract][Full Text] [Related]
20. The calcium-sensing receptor mediates hypoxia-induced proliferation of rat pulmonary artery smooth muscle cells through MEK1/ERK1,2 and PI3K pathways.
Li GW; Xing WJ; Bai SZ; Hao JH; Guo J; Li HZ; Li HX; Zhang WH; Yang BF; Wu LY; Wang R; Yang GD; Xu CQ
Basic Clin Pharmacol Toxicol; 2011 Mar; 108(3):185-93. PubMed ID: 21073657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
